Simvastatin in phase III

[frodo]

Simvastatin starting a phase III trial. This is important because it is not an immune modulator. It is a cholesterol lowering drug and if it works, it will open new research paths about MS pathogenesis.

https://www.mssociety.org.uk/research/l ... ecruitment

MS-STAT2 is investigating whether cholesterol-lowering drug simvastatin slows disability progression in secondary progressive MS. It’s a phase 3 trial. So it’s the final, definitive stage of testing following positive smaller trials.

With recruitment finishing, we’re a step closer to knowing whether simvastatin could be the first treatment for people with progressive MS that protects nerves from damage in MS.